61 results
Page 3 of 4
6-K
EX-99.1
9fpuwd7hn0s fj
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
jeetfw2l6cyft2d
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.1
yk3wg55d
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
jm2rpp9b8z8e4dw
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
EX-99.2
mxk505
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
EX-99.1
nmffhzzzwh vk
17 May 21
Connect Biopharma Announces First
5:27pm
424B4
25y7j ljy9
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
v0i9czaq7o0
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
l9wqhlimyo23r
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
3lwoldb pupfe
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
u6huxjgps ma
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
heulb ljowt
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.10
o6xfa
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.13
6xgftrmg m48evulj0b
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.9
mdyq9vt6ln1hbl
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
4nx1o68
26 Jan 21
Draft registration statement (amended)
12:00am
DRSLTR
ci7tdnm
26 Jan 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
b3jgz9gn5 61aac9v
13 Jan 21
Letter from SEC
12:00am
DRS
EX-10.6
2hn3o w02
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
o6bxbeup
17 Dec 20
Draft registration statement
12:00am